Herbas VPB

Print
EN | LT
LT - ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT
EN - ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/46
A61K 39/02
A61K 39/04
C07K 1/00
C07K 14/00
C07K 17/00
A61P 35/00
European patent
(11) Number of the document 2968482
(13) Kind of document T
(96) European patent application number 14769340.2
Date of filing the European patent application 2014-03-13
(97) Date of publication of the European application 2016-01-20
(45) Date of publication and mention of the grant of the patent 2020-05-06
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/026766
Date 2014-03-13
PCT application publication
(87) Number WO 2014/151982
Date 2014-09-25
Priority applications
(30) Number Date Country code
201361790833 P 2013-03-15 US
Inventors
(72)
ALMASSY, Robert, US
SHOWALTER, Richard E., US
THOMSON, James A., US
SISSON, Wes, US
SHIA, Wei-Jong, US
CHEN, Li-Chang, US
LEE, Yang, US
Grantee
(73) TDW Group, 4F, No.631 Ruiguang Road Neihu District, Taipei, 11492, TW
Title
(54) ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT
  ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT
Last update date 2021-04-30